07 January 2022>: Meta-Analysis
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: A Meta-Analysis
Wenjie Sun AE , Junqiang Yan AFG* , Jiannan Wu BC , Hongxia Ma BDDOI: 10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074
Table 1 Demographic and clinical data of the included study.
Study ID (n1/n2) | Age/years | Female/Male | Hoehn & Yahr | UPDRS III | ESS | Depression | Country/ region | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXP | CON | EXP | CON | EXP | CON | EXP | CON | EXP | CON | EXP | CON | ||
Videnovic 2017 (16/15) | 63.31 | 64.07 | 8/8 | 10/5 | 2.09 | 2.3 | 24.75 | 29.13 | 15.81 | 15.47 | 8.31/BDI | 8.27/BDI | USA/Illinois |
Rutten 2016–2019 (35/37) | 58.9 | 65.8 | 15/20 | 17/20 | 2.11 | 2.38 | 20.7 | 23.9 | . | . | 14.7/HDRS | 14.5/HDRS | Netherlands |
Rutten 2019 (45/47) | 70.2 | 65.9 | 12/32 | 17/30 | 2.18 | 2.15 | 39.8 | 37.1 | 9.4 | 8.4 | 8.2/BDI | 8.3/BDI | i) Netherlands /Amsterdam ii) USA /Massachusetts iii) USA/Utah |
Willis 2018 (10/10) | 66.9 | 70.8 | 4/6 | 4/6 | . | . | . | . | 6.1 | 7.7 | 9BDI | 9.4/BDI | Australia/Victoria |
Raymackers 2019 (8/8) | 66.5 | 68.88 | 4/4 | 6/2 | . | . | . | . | 12.75 | 5.5 | 5.88/HADS | 5.88/HADS | Belgium |
Overall (113/117) | 65.79 | 66.25 | 43/70 | 54/63 | 2.13 | 2.26 | 30.32 | 30.96 | 10.6 | 9.34 | . | . | . |
UPDRS III – Unified Parkinsons Disease Rating Scale III; ESS – Epworth Sleepiness Scale; BDI – Back Depression Inventory; HDRS – Hamilton Depression Scale; HADS – Hospital Anxiety and Depression Scale. |